By divesting its extremity orthopedics business to Smith & Nephew, Integra LifeSciences should be able to focus on areas with a higher potential for growth.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,